Form 4: Novanta CFO Exercises, Sells Shares Under 10b5-1 Plan

Novanta Inc.'s Chief Financial Officer, Robert Buckley, exercised stock options and subsequently sold 1,423 shares of common stock on January 21, 2026, under a pre-established 10b5-1 trading plan.

Summary

• Robert Buckley, Chief Financial Officer of Novanta Inc. (NOVT), reported transactions on January 21, 2026.
• Buckley exercised stock options to acquire 1,423 shares of Common Stock at an exercise price of $14.13 per share.
• Concurrently, Buckley sold 1,423 shares of Common Stock at a weighted-average price of $140.1435 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.
• Following these transactions, Buckley directly beneficially owns 91,034 shares of Common Stock and 11,380 stock options.
• Additionally, 36,219 shares of Common Stock are indirectly beneficially owned through the Buckley Family Irrevocable Trust.
• The stock options exercised had vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019, and are set to expire on March 30, 2026.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While it's a sale by an insider, it was pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling. The significant gain realized by the CFO from the option exercise reflects positively on the company's stock performance over time.

Positives

• The significant difference between the option exercise price ($14.13) and the sale price ($140.1435) indicates substantial value creation for the officer and reflects strong historical stock performance for Novanta Inc.
• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, which demonstrates a commitment to transparent and compliant insider trading practices.

Negatives

• The sale of shares by a Chief Financial Officer, even if pre-planned, could be interpreted by some investors as a reduction in direct exposure to the company's equity.

Future Outlook

This Form 4 filing is a transactional report and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider transaction by a corporate officer, which is a common occurrence across all industries. It does not provide specific insights into broader industry trends or competitive landscape beyond reflecting the company's stock performance.

Corporate Governance

Related Party Transactions

• Robert Buckley indirectly beneficially owns 36,219 shares of Common Stock through the Buckley Family Irrevocable Trust, which is a standard disclosure for insider ownership.

Stakeholder Impact

• Shareholders: May view the transaction as a routine, pre-planned event, or as a positive signal of past stock performance given the significant gain realized by the CFO. Some might view the sale as a slight reduction in management's direct equity alignment.
• Employees: No direct impact mentioned.

Next Steps

• The remaining 11,380 stock options held by Robert Buckley are set to expire on March 30, 2026, unless exercised prior to that date.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction (exercise and sale) by the CFO under a pre-established 10b5-1 trading plan. Such transactions, especially when pre-planned, typically do not signal new material information about the company's future performance. The significant difference between the exercise price and sale price indicates strong past stock performance, which is positive. However, the sale itself doesn't provide a strong buy signal, nor does it suggest a sell-off. Therefore, a 'hold' recommendation is appropriate as this filing alone does not alter the fundamental investment thesis.

Keywords

Novanta Inc., NOVT, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Robert Buckley, CFO, 10b5-1 Plan